Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Magnit recommended that dividends be paid for 9 мес. 2024

11/29/24 MGNT

Inter RAO's profit for the first 9 months of 2024 increased by 14%

11/29/24 IRAO

Alrosa sells stake in Angola's Catoca

11/29/24 ALRS

Sistema earned ₽1.8 billion in 9 months of 2024

11/29/24 AFKS

Rosseti Ural's net profit for the first 9 months of 2024 increased by almost 5%

11/28/24 MRKU

Shareholders of Whoosh approved dividends for 9 months 2024

11/28/24 WUSH

The Moscow Exchange transfers securities from the high-risk sector to the main trading mode

11/28/24 MOEX

VseInstrumentyru's net profit for 9 months of 2024 decreased by 95%

11/28/24 VSEH

Etalon to build 8 residential districts in Rostov-on-Don

11/28/24 ETLN

Moscow Exchange to resume morning trading on the derivatives market

11/28/24 MOEX